Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings
Go back to Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 0.52 -0.25 (32.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $9.58 | |||
| Open | $0.72 | 52 Week Low | $2.34 | |||
| Day High | $0.73 | P/E | N/A | |||
| Day Low | $0.50 | EPS | $-0.34 | |||
| Volume | 4,080,132 | |||||
